Please wait...
About This Project
OncoSynergy, Inc.
The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
Browse Other Projects on Experiment
Related Projects
Urban Pollination: sustain native bees & urban crops
Bee activity on our crop flowers is crucial to human food security, but bees are also declining around the...
Cannibalism in Giant Tyrannosaurs
This is the key question we hope to answer with this study. This project is to fund research into a skull...
Seattle HiveBio Community Lab
Thank you to everyone who has supported HiveBio thus far. As of April 17th we've reached our basic funding...
